Tenaya Therapeutics Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | |
| – | +24.8% | +19.3% | +118.4% | +34.3% | -2.5% | +4.5% | |
| – | +79.0% | +298.1% | +288.7% | +33.5% | +7.8% | -20.9% | |
| – | +76.5% | +330.8% | +288.0% | – | – | – | |
| – | – | – | -117.9% | – | – | – | |
| – | +233.7% | +157.3% | -17.9% | -94.0% | -17.3% | -39.7% | |
| – | +25.6% | +3,303.2% | – | -41.8% | -97.7% | +4,858.7% | |
| – | -66.7% | +1,200.0% | – | – | – | – | |
| – | +382.7% | +41.9% | -62.8% | -94.8% | +1,079.3% | +127.0% | |
| – | +12,497.5% | -186.3% | – | -186.5% | – | – | |
| – | – | – | – | – | – | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.